Figure 2From: Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1Illustrating the different therapeutic approaches targeting the GLP-1 axis and mechanistic considerations for each[46–48]. The possibilities of GLP-1 receptor independent effects and GLP-1 (28–36) and (32–36) mediated effects need validation.Back to article page